Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Base4Biotech-Servier

More Like This

PR Newswire associated0

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

PR Newswire associated0

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Dev4All and Pharmaseed Join Forces in Commercial Cooperation (Graphic: Business Wire)

Dev4All and Pharmaseed Join Forces in Commercial Cooperation to Boost Preclinical Development Services

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

GlobeNewswire associated0

Development Bank of Japan invests in 4BIO Capital’s Ventures III fund

Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms

Transforming the Future of Medicine with RNA-Based Therapies

PR Newswire associated0

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel, Switzerland Location